Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology
Read more at globenewswire.comCytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Provided By GlobeNewswire – Last update: